US Bancorp’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.22K | Sell |
295
-1,262
| -81% | -$9.5K | ﹤0.01% | 3845 |
|
|
2025
Q1 | $11.8K | Buy |
1,557
+1,344
| +631% | +$10.2K | ﹤0.01% | 3368 |
|
|
2024
Q4 | $2.6K | Buy |
213
+96
| +82% | +$1.17K | ﹤0.01% | 3801 |
|
|
2024
Q3 | $1.96K | Buy |
117
+12
| +11% | +$201 | ﹤0.01% | 3774 |
|
|
2024
Q2 | $1.83K | Sell |
105
-323
| -75% | -$5.63K | ﹤0.01% | 3713 |
|
|
2024
Q1 | $7.29K | Sell |
428
-76
| -15% | -$1.3K | ﹤0.01% | 3414 |
|
|
2023
Q4 | $5.14K | Buy |
+504
| New | +$5.14K | ﹤0.01% | 3516 |
|
|
2023
Q2 | – | Sell |
-1,084
| Closed | -$11.1K | – | 3971 |
|
|
2023
Q1 | $11.1K | Buy |
1,084
+517
| +91% | +$5.29K | ﹤0.01% | 3230 |
|
|
2022
Q4 | $5.98K | Sell |
567
-110
| -16% | -$1.16K | ﹤0.01% | 3440 |
|
|
2022
Q3 | $9K | Buy |
677
+186
| +38% | +$2.47K | ﹤0.01% | 3375 |
|
|
2022
Q2 | $6K | Sell |
491
-1,267
| -72% | -$15.5K | ﹤0.01% | 3491 |
|
|
2022
Q1 | $18K | Buy |
1,758
+308
| +21% | +$3.15K | ﹤0.01% | 3112 |
|
|
2021
Q4 | $22K | Buy |
1,450
+1,440
| +14,400% | +$21.8K | ﹤0.01% | 3044 |
|
|
2021
Q3 | $0 | Buy |
+10
| New | – | ﹤0.01% | 4042 |
|